News Vir Biotechnology Announces New Clinical Data From its Broad Hepatitis B Program Continue Reading Previous Arbutus Presents New Data on AB-729, AB-836 and AB-101 at the EASL International Liver Congressā¢Ā 2022 and Provides AB-836 Clinical UpdateNext Madrigal Pharmaceuticals Presents Late-Breaking Phase 3 NASH Data and Multiple Oral Abstracts at EASLās International Liver Congress⢠Related Stories News Quest Unveils AI to Cut Identity Threat Response Without Deep AD Skills News Snail, Inc. Announces Intent to Explore Proprietary USD-Backed Stablecoin News Talkdesk expands global network of regional cloud deployments with new UK Regional Cloud News Zuken Vitech Announces Launch of Sidekickā¢: A Web Companion to GENESYS Designed to Streamline Model-Based Systems Engineering Collaboration News Locus Technologies Expands Water Software Suite with the Launch of its Backflow Prevention App News Xsolis Launches AI Amplified, a New Podcast Hosted by Chief Medical Officer Dr. Heather Bassett, Spotlighting the Real-World Impact of AI in Healthcare